Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

102.45
Delayed Data
As of Feb 12
 +2.86 / +2.87%
Today’s Change
92.98
Today|||52-Week Range
140.72
-14.45%
Year-to-Date

Today’s Trading

Previous close99.59
Today’s open100.99
Day’s range97.45 - 102.77
Volume6,009,369
Average volume (3 months)5,772,213
Market cap$80.1B
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-18.83%
Earnings growth (this year)+20.53%
Earnings growth (next 5 years)+23.00%
Revenue growth (last year)+21.11%
P/E ratio51.4
Price/Sales10.67
Price/Book--

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co-0.15-0.21%
AZNAstraZeneca+0.51+1.75%
ABBVAbbVie+0.40+0.77%
GSKGlaxoSmithKline+0.61+1.56%
Data as of 4:03pm ET, 02/12/2016

Financials

Next reporting dateApril 21, 2016
EPS forecast (this quarter)$1.27
Annual revenue (last year)$9.3B
Annual profit (last year)$1.6B
Net profit margin17.31%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert J. Hugin
President, Chief Operating Officer &
Director
Mark J. Alles
Corporate headquarters
Summit, New Jersey

Forecasts

Partner Offers